Interferon-Beta-1a (Rebif)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Interferon-Beta-1a (Rebif), covering 2013-08-06 to 2017-07-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis [Phase 3]